SaNOtize
He is a pioneer in nitric oxide technology and therapeutic research.
He is a co-founder and CEO/CSO experience in nitric oxide biotech startup fundraising and out licensing. He has 20 years of expertise in design & execution of clinical trials, 20 years of experience in Intellectual Property, regulatory and management. He is a Retired Assistant Professor in the Faculty of Medicine, Respiratory & Infectious Diseases Divisions, University of British Columbia, Canada.
He holds a PhD in Experimental Medicine and degrees in Health Management and Respiratory Therapy.
SaNOtize
SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections.